<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Mercaptopurine</strong></td></tr><tr><th>Accession Number</th><td><strong>DB01033</strong>&#160; (APRD01096)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB01033/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB01033/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01033.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01033.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01033.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01033.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01033.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB01033">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>6 MP</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>6-Mercaptopurine</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>6-MP</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>6-Thioxopurine</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Mercapurin</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Mercaptopurine monohydrate</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT001026/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT001026/thumb.png"></a></td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT001026">DBSALT001026</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Leukerin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Purinethol</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/immunosuppressive-agents">Immunosuppressive Agents</a></li>
<li><a href="/mesh/antimetabolites">Antimetabolites</a></li>
<li><a href="/mesh/nucleic-acid-synthesis-inhibitors">Nucleic Acid Synthesis Inhibitors</a></li>
<li><a href="/mesh/antimetabolites-antineoplastic">Antimetabolites, Antineoplastic</a></li>
<li><a href="/mesh/purine-analogues">Purine analogues</a></li></ul></td></tr><tr><th>CAS number</th><td>50-44-2</td></tr><tr><th>Weight</th><td>Average: 152.177<br>Monoisotopic: 152.015666838</td></tr><tr><th>Chemical Formula</th><td>C<sub>5</sub>H<sub>4</sub>N<sub>4</sub>S</td></tr><tr><th>InChI Key</th><td>GLVAUDGFNGKCSF-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">6,7-dihydro-3H-purine-6-thione</div></td></tr><tr><th>SMILES</th><td><div class="wrap">S=C1N=CNC2=C1NC=N2</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Heterocyclic Compounds</td></tr><tr><th>Class</th><td>Imidazopyrimidines</td></tr><tr><th>Subclass</th><td>Purines and Purine Derivatives</td></tr><tr><th>Direct parent</th><td>Purinethiones</td></tr><tr><th>Alternative parents</th><td>Pyrimidinethiones; Imidazoles; Polyamines</td></tr><tr><th>Substituents</th><td>pyrimidinethione; pyrimidine; imidazole; azole; polyamine; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the purinethiones. These are purines in which the purine moiety bears a thioketone.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For remission induction and maintenance therapy of acute lymphatic leukemia.</td></tr><tr><th>Pharmacodynamics</th><td>Mercaptopurine is one of a large series of purine analogues which interfere with nucleic acid biosynthesis and has been found active against human leukemias. It is an analogue of the purine bases adenine and hypoxanthine. It is not known exactly which of any one or more of the biochemical effects of mercaptopurine and its metabolites are directly or predominantly responsible for cell death.</td></tr><tr><th>Mechanism of action</th><td>Mercaptopurine competes with hypoxanthine and guanine for the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRTase) and is itself converted to thioinosinic acid (TIMP). This intracellular nucleotide inhibits several reactions involving inosinic acid (IMP), including the conversion of IMP to xanthylic acid (XMP) and the conversion of IMP to adenylic acid (AMP) via adenylosuccinate (SAMP). In addition, 6-methylthioinosinate (MTIMP) is formed by the methylation of TIMP. Both TIMP and MTIMP have been reported to inhibit glutamine-5-phosphoribosylpyrophosphate amidotransferase, the first enzyme unique to the de novo pathway for purine ribonucleotide synthesis. Experiments indicate that radiolabeled mercaptopurine may be recovered from the DNA in the form of deoxythioguanosine. Some mercaptopurine is converted to nucleotide derivatives of 6-thioguanine (6-TG) by the sequential actions of inosinate (IMP) dehydrogenase and xanthylate (XMP) aminase, converting TIMP to thioguanylic acid (TGMP).</td></tr><tr><th>Absorption</th><td>Clinical studies have shown that the absorption of an oral dose of mercaptopurine in humans is incomplete and variable, averaging approximately 50% of the administered dose. The factors influencing absorption are unknown.</td></tr><tr><th>Volume of distribution</th><td><p>The volume of distribution exceeded that of the total body water.</p></td></tr><tr><th>Protein binding</th><td>Plasma protein binding averages 19% over the concentration range 10 to 50 &#181;g/mL (a concentration only achieved by intravenous administration of mercaptopurine at doses exceeding 5 to 10 mg/kg).</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Hepatic. Degradation primarily by xanthine oxidase. The catabolism of mercaptopurine and its metabolites is complex. In humans, after oral administration of <sup>35</sup>S-6-mercaptopurine, urine contains intact mercaptopurine, thiouric acid (formed by direct oxidation by xanthine oxidase, probably via 6-mercapto-8-hydroxypurine), and a number of 6-methylated thiopurines. The methylthiopurines yield appreciable amounts of inorganic sulfate.</p><table class="table-standard table-condensed" id="experimental-properties"><thead><tr><th>Substrate</th><th>Enzymes</th><th colspan="2">Product</th></tr></thead><tbody><tr><td>Mercaptopurine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0000077" target="_blank">Hypoxanthine-guanine phosphoribosyltransferase</a></li></ul></td><td><a href="/metabolites/DBMET00657">6-Thioinosine 5'-monophosphate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1283">Details</a></td></tr><tr><td><a href="/metabolites/DBMET00657">6-Thioinosine 5'-monophosphate</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0000321" target="_blank">GMP synthase [glutamine-hydrolyzing]</a></li></ul></td><td><a href="/metabolites/DBMET01151">Thioxanthine monophosphate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1284">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01151">Thioxanthine monophosphate</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0000321" target="_blank">GMP synthase [glutamine-hydrolyzing]</a></li></ul></td><td><a href="/metabolites/DBMET01152">Thioguanosine monophosphate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1285">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01152">Thioguanosine monophosphate</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0000987" target="_blank">Thiopurine S-methyltransferase</a></li></ul></td><td><a href="/metabolites/DBMET01153">Methyl-thioguanosine monophosphate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1286">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01152">Thioguanosine monophosphate</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01154">Thioguanosine diphosphate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1287">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01154">Thioguanosine diphosphate</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01155">Thioguanosine triphosphate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1288">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01154">Thioguanosine diphosphate</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01156">Thiodeoxyguanosine diphosphate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1289">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01156">Thiodeoxyguanosine diphosphate</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01157">Thiodeoxyguanosine triphosphate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1290">Details</a></td></tr><tr><td><a href="/metabolites/DBMET00657">6-Thioinosine 5'-monophosphate</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0000987" target="_blank">Thiopurine S-methyltransferase</a></li></ul></td><td><a href="/metabolites/DBMET01158">Methyl-thioinosine 5'-monophospate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1291">Details</a></td></tr><tr><td><a href="/metabolites/DBMET00657">6-Thioinosine 5'-monophosphate</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET01159">6-Mercaptopurine riboside</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1292">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01159">6-Mercaptopurine riboside</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0000987" target="_blank">Thiopurine S-methyltransferase</a></li></ul></td><td><a href="/metabolites/DBMET01160">6-Methylmercaptopurine-riboside</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1293">Details</a></td></tr><tr><td><a href="/metabolites/DBMET01160">6-Methylmercaptopurine-riboside</a></td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0003540" target="_blank">Adenosine kinase</a></li></ul></td><td><a href="/metabolites/DBMET01158">Methyl-thioinosine 5'-monophospate</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1294">Details</a></td></tr><tr><td>Mercaptopurine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0003539" target="_blank">Aldehyde oxidase</a></li></ul></td><td><a href="/metabolites/DBMET00780">8-hydroxythioguanine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1295">Details</a></td></tr><tr><td>Mercaptopurine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0002204" target="_blank">Xanthine dehydrogenase/oxidase</a></li></ul></td><td><a href="/metabolites/DBMET01161">Thiouric acid</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1296">Details</a></td></tr><tr><td>Mercaptopurine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0000987" target="_blank">Thiopurine S-methyltransferase</a></li></ul></td><td><a href="/metabolites/DBMET01162">Methylmercaptopurine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/1297">Details</a></td></tr></tbody></table></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td>Triphasic: 45 minutes, 2.5 hours, and 10 hours.</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>Signs and symptoms of overdosage may be immediate such as anorexia, nausea, vomiting, and diarrhea; or delayed such as myelosuppression, liver dysfunction, and gastroenteritis. The oral LD<sub>50</sub> of mercaptopurine was determined to be 480 mg/kg in the mouse and 425 mg/kg in the rat.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td class="data-table-container"><table class="table table-condensed table-striped" id="pathways"><thead><tr><th>Pathway</th><th>Category</th></tr></thead><tbody><tr><td>Thioguanine Action Pathway</td><td>Drug action</td></tr><tr><td>Azathioprine Action Pathway</td><td>Drug action</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00427?highlight%5Bcompounds%5D%5B%5D=DB01033&amp;highlight%5Bproteins%5D%5B%5D=DB01033">SMP00427</a></td></tr><tr><td>Mercaptopurine Action Pathway</td><td>Drug action</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00428?highlight%5Bcompounds%5D%5B%5D=DB01033&amp;highlight%5Bproteins%5D%5B%5D=DB01033">SMP00428</a></td></tr><tr><td>Azathioprine Metabolism Pathway</td><td>Drug metabolism</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00645?highlight%5Bcompounds%5D%5B%5D=DB01033&amp;highlight%5Bproteins%5D%5B%5D=DB01033">SMP00645</a></td></tr><tr><td>Mercaptopurine Metabolism Pathway</td><td>Drug metabolism</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00609?highlight%5Bcompounds%5D%5B%5D=DB01033&amp;highlight%5Bproteins%5D%5B%5D=DB01033">SMP00609</a></td></tr></tbody></table></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="snp-fx"><thead><tr><th>Interacting Gene/Enzyme</th><th>SNP RS ID</th><th>Allele name</th><th>Defining change</th><th>Adverse Reaction</th><th>Reference(s)</th></tr></thead><tbody><tr><td>Thiopurine S-methyltransferase<br>Gene symbol: TPMT<br>UniProt: <a class="wishart-link-out" href="http://www.uniprot.org/uniprot/P51580" target="_blank">P51580 <span class="glyphicon glyphicon-new-window"> </span></a></td><td><a class="wishart-link-out" href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=rs1800462" target="_blank">rs1800462 <span class="glyphicon glyphicon-new-window"> </span></a></td><td>TMPT*2</td><td>G Allele</td><td>Hepatotoxicity</td><td><span class="citation"><a class="pubmed-link wishart-link-out" data-toggle="tooltip" href="http://www.ncbi.nlm.nih.gov/pubmed/16509759" target="_blank" title="Bosch TM, Meijerman I, Beijnen JH, Schellens JH: Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin Pharmacokinet. 2006;45(3):253-85.">16509759 <span class="glyphicon glyphicon-new-window"> </span></a></span></td></tr><tr><td>Thiopurine S-methyltransferase<br>Gene symbol: TPMT<br>UniProt: <a class="wishart-link-out" href="http://www.uniprot.org/uniprot/P51580" target="_blank">P51580 <span class="glyphicon glyphicon-new-window"> </span></a></td><td><a class="wishart-link-out" href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=rs1800460" target="_blank">rs1800460 <span class="glyphicon glyphicon-new-window"> </span></a></td><td>TMPT*3A</td><td>A Allele</td><td>Hepatotoxicity</td><td><span class="citation"><a class="pubmed-link wishart-link-out" data-toggle="tooltip" href="http://www.ncbi.nlm.nih.gov/pubmed/16509759" target="_blank" title="Bosch TM, Meijerman I, Beijnen JH, Schellens JH: Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin Pharmacokinet. 2006;45(3):253-85.">16509759 <span class="glyphicon glyphicon-new-window"> </span></a></span></td></tr><tr><td>Thiopurine S-methyltransferase<br>Gene symbol: TPMT<br>UniProt: <a class="wishart-link-out" href="http://www.uniprot.org/uniprot/P51580" target="_blank">P51580 <span class="glyphicon glyphicon-new-window"> </span></a></td><td><a class="wishart-link-out" href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=rs1142345" target="_blank">rs1142345 <span class="glyphicon glyphicon-new-window"> </span></a></td><td>TMPT*3C</td><td>G Allele</td><td>Hepatotoxicity</td><td><span class="citation"><a class="pubmed-link wishart-link-out" data-toggle="tooltip" href="http://www.ncbi.nlm.nih.gov/pubmed/16509759" target="_blank" title="Bosch TM, Meijerman I, Beijnen JH, Schellens JH: Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin Pharmacokinet. 2006;45(3):253-85.">16509759 <span class="glyphicon glyphicon-new-window"> </span></a></span></td></tr></tbody></table></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.8854</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.8946</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.6556</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.7141</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9143</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9848</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8543</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8607</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.8533</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.7949</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Inhibitor</td>
        <td>0.7555</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.6955</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8224</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.7472</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8309</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.6635</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.5076
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9369
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9972
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.3684 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9857
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.8734
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Mylan pharmaceuticals inc</li>
<li>Prometheus laboratories inc</li>
<li>Roxane laboratories inc</li>
<li>Teva pharmaceuticals usa inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.amerisourcebergen.com">Amerisource Health Services Corp.</a></li>
<li><a href="http://www.dsm.com">DSM Corp.</a></li>
<li>Gate Pharmaceuticals</li>
<li><a href="http://www.medisca.com">Medisca Inc.</a></li>
<li><a href="http://www.mylan.com">Mylan</a></li>
<li><a href="http://www.parpharm.com">Par Pharmaceuticals</a></li>
<li><a href="http://www.roxane.com">Roxane Labs</a></li>
<li><a href="http://www.stasonpharma.com">Stason Pharmaceuticals Inc.</a></li>
<li><a href="http://www.tevapharm.com">Teva Pharmaceutical Industries Ltd.</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Tablet</td><td>Oral</td><td>50 mg</td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01418">Acenocoumarol</a></td><td>Mercaptopurine may decrease the anticoagulant effect of acenocoumarol.</td></tr><tr><td><a href="/drugs/DB00437">Allopurinol</a></td><td>Allopurinol may increase the effect of thiopurine, mercaptopurine.</td></tr><tr><td><a href="/drugs/DB00233">Aminosalicylic Acid</a></td><td>Aminosalicylic acid may increase the toxicity of thiopurine, mercaptopurine.</td></tr><tr><td><a href="/drugs/DB01125">Anisindione</a></td><td>Mercaptopurine may decrease the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB00732">Atracurium</a></td><td>The agent dereases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00266">Dicoumarol</a></td><td>Mercaptopurine may decrease the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01135">Doxacurium chloride</a></td><td>The agent dereases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB04854">Febuxostat</a></td><td>Coadministration of febuxostat with xanthine oxidase substrate drugs (azathioprine, mercaptopurine or theophylline) could increase plasma concentrations of these drugs, since these drugs are metabolized by xanthine oxidase, resulting in severe toxicity; hence their concomitant use is contraindicated. Since febuxostat does not inhibit or induce cytochrome P450 enzymes it lacks significant drug interactions with other drugs metabolized of these enzymes.</td></tr><tr><td><a href="/drugs/DB00244">Mesalazine</a></td><td>Mesalazine may increase the toxicity of thiopurine, mercaptopurine.</td></tr><tr><td><a href="/drugs/DB01336">Metocurine</a></td><td>The agent dereases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB01226">Mivacurium</a></td><td>The agent dereases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB01250">Olsalazine</a></td><td>Olsalazine may increase the toxicity of thiopurine, mercaptopurine.</td></tr><tr><td><a href="/drugs/DB01337">Pancuronium</a></td><td>The agent dereases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00795">Sulfasalazine</a></td><td>Sulfasalazine may increase the toxicity of thiopurine, mercaptopurine.</td></tr><tr><td><a href="/drugs/DB00352">Tioguanine</a></td><td>Complete cross resistance may occur. </td></tr><tr><td><a href="/drugs/DB00072">Trastuzumab</a></td><td>Trastuzumab may increase the risk of neutropenia and anemia. Monitor closely for signs and symptoms of adverse events. </td></tr><tr><td><a href="/drugs/DB01199">Tubocurarine</a></td><td>The agent dereases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB01339">Vecuronium</a></td><td>The agent dereases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00682">Warfarin</a></td><td>Mercaptopurine may decrease the anticoagulant effect of warfarin.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Preferably on an empty stomach, drink plenty of liquids, avoid alcohol.</li></ul></td></tr></tbody></table>